William Blair Investment Management LLC acquired a new stake in Quanterix Co. (NASDAQ:QTRX – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,062,105 shares of the company’s stock, valued at approximately $11,290,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Portolan Capital Management LLC increased its position in Quanterix by 31.4% in the 3rd quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company’s stock valued at $32,668,000 after acquiring an additional 602,656 shares during the period. Geode Capital Management LLC increased its holdings in Quanterix by 2.2% in the third quarter. Geode Capital Management LLC now owns 858,667 shares of the company’s stock valued at $11,131,000 after purchasing an additional 18,231 shares during the period. State Street Corp increased its holdings in Quanterix by 2.2% in the third quarter. State Street Corp now owns 836,443 shares of the company’s stock valued at $10,840,000 after purchasing an additional 18,050 shares during the period. Pier Capital LLC increased its stake in shares of Quanterix by 23.5% in the third quarter. Pier Capital LLC now owns 511,798 shares of the company’s stock valued at $6,633,000 after buying an additional 97,256 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in shares of Quanterix by 28.1% in the third quarter. JPMorgan Chase & Co. now owns 217,957 shares of the company’s stock valued at $2,825,000 after buying an additional 47,873 shares during the period. 86.48% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group decreased their price target on Quanterix from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Tuesday.
Quanterix Trading Up 0.7 %
Shares of Quanterix stock opened at $7.20 on Thursday. The business has a 50-day moving average price of $8.32 and a two-hundred day moving average price of $10.90. Quanterix Co. has a 1-year low of $6.30 and a 1-year high of $27.37. The company has a market cap of $277.37 million, a P/E ratio of -6.79 and a beta of 1.34.
Quanterix (NASDAQ:QTRX – Get Free Report) last released its earnings results on Monday, March 17th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.03). Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. The business had revenue of $35.16 million for the quarter, compared to analyst estimates of $34.93 million. Equities research analysts forecast that Quanterix Co. will post -0.98 EPS for the current fiscal year.
Quanterix Company Profile
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
See Also
- Five stocks we like better than Quanterix
- What Are Trending Stocks? Trending Stocks Explained
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Healthcare Dividend Stocks to Buy
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Co. (NASDAQ:QTRX – Free Report).
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.